Earnings Releases·Nov 5, 2026, 4:10 PM ET

CVRx — Third Quarter 2026 Earnings Summary

Q3 2026 total revenue declined 6% year-over-year to $13.8 million, driven by lower U.S. sales force productivity and payer challenges, while net loss widened to $14.2 million ($0.52 per share) from $12.9 million in the prior year period.
Full-year 2026 total revenue guidance was lowered to $56.0–$57.0 million (from $58.0–$60.0 million), with Q4 revenue expected between $11.7 million and $12.7 million, alongside a strategic focus on cost reductions in non-commercial functions and R&D.
Strategic progress includes expanded Medicare Advantage coverage affecting 21% of enrollment and the presentation of late-breaking REBALANCE Registry data, though the company faces risks regarding product dependence and competitor development.
Key leadership and capital changes include the appointment of John Landry as CFO effective November 6, 2026, a net cash burn of $11.0 million in the quarter, and a reduction in cash and cash equivalents to $58.7 million.